Navigation Links
Dilon Diagnostics Gamma-Guided Localization System Cleared by FDA
Date:12/14/2009

GammaLMc® Helps Locate Breast Lesions Quickly and Accurately for Biopsy

Newport News, VA (Vocus) December 14, 2009 -- Dilon Diagnostics announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its lesion-localization system for molecular imaging biopsy guidance.

GammaLMc® is a complementary technology to Dilon’s cornerstone product, the Dilon 6800 Gamma Camera. The GammaLMc® (GL) system will help doctors accurately locate breast lesions and enable gamma-guided biopsies, particularly useful for patients that have findings on the Dilon system that are not revealed with other imaging modalities.

The GammaLMc® system utilizes a CorreLocator™ paddle and a StereoView™ imaging collimator system - a technique similar to that used in stereotactic X-ray localization, and the GammaLMc® software calculates the specific location of the suspect lesion. The compact design allows for breast biopsies with optimal patient comfort; and the entire system is small and portable, allowing physicians to perform molecular imaging guided biopsy procedures anywhere on site.

“Thanks to the superior performance of the Dilon 6800 camera combined with this new biopsy-guidance capability, physicians will find it easier to locate suspicious lesions seen with molecular breast imaging, greatly facilitating and expediting the biopsy process,” said Robert Moussa, President and CEO of Dilon Diagnostics. “This recent innovation helps physicians improve patient management and confidently deliver faster, more accurate results to their anxious patients.”

About Dilon Diagnostics:
Dilon Diagnostics, a brand of Dilon Technologies Inc. is bringing innovative new medical imaging products to market. Dilon’s cornerstone product, the Dilon 6800, is a high-resolution, small field-of-view gamma camera, optimized to perform BSGI, a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake. Many leading medical centers around the country are now offering BSGI to their patients, including: Cornell University Medical Center, New York; George Washington University Medical Center, Washington, D.C.; and The Rose, Houston. For more information on Dilon Technologies please visit www.dilon.com.

###

Read the full story at http://www.prweb.com/releases/2009/12/prweb3341114.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Dilon Technologies Explores Improvements in Molecular Breast Imaging
2. Dilon Technologies Appoints New VP of Sales & Business Development
3. Settlement Reached Between Dilon Technologies and Naviscan on Patent Rights
4. Dilon Technologies Announces National Agreement with MedAssets
5. Dilon Technologies Signs Amerinet for Breast-Specific Gamma Imaging
6. Dilon Technologies Slant15(TM) and LEHR Collimators Enhance Imaging Capabilities
7. Dilon Technologies Leads Molecular Breast Imaging Expansion
8. Quest Diagnostics to Speak at the Bear Stearns Healthcare Conference
9. Pathway Diagnostics Announces Commercial Availability of SensiTrop(TM) HIV Co-receptor Tropism Assay
10. Hypertension Diagnostics Announces Fiscal Year 2007 Results
11. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... 2016 , ... Penrose Senior Care Auditors® was announced as ... at the 26th Annual SMU Cox Dallas 100™ Awards Ceremony and Banquet held ... Entrepreneurship. Dallas 100™, co-founded by the Caruth Institute, honors the ingenuity, commitment and ...
(Date:12/4/2016)... ... ... Are You Concerned About Mold In Your Home or Workplace? Madison ... in VA, MD and DC, recently completed its application for the new District of ... the district of Columbia is a good thing stated John Taylor, Owner of Madison ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Lori G. ... Traurig, LLP’s Atlanta office, will speak at the American Conference Institute’s 21st Drug ... Traurig is also a Lead Sponsor of the conference. , Cohen, who chairs the ...
(Date:12/2/2016)... ... ... For over twenty-four years, Doctors on Liens has published a directory of the ... medical care. When the company started in 1997, the directory was a single page ... the now ten-page directory features a vast array of medical specialists stretching from ...
(Date:12/2/2016)... ... December 02, 2016 , ... FlexiSpot, a trusted name in ... trial program for all of the company’s desktop riser products. A simple application ... experience. , FlexiSpot’s unique desktop risers use an advanced dual gas spring hovering ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... 2016 bioLytical Laboratories, un líder mundial en test rápidos ... HIV Self Test , a los miembros de la Kenya Pharmaceutical Association. ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) bioLytical fue invitada por la ...
(Date:12/2/2016)... held the largest share in the ECG Cables And ECG ... for remote monitoring ECG devices. On the other hand, the ... witness the highest growth rate during the forecast period. ... and Company (U.S.), Medtronic plc ( Ireland ), ... Mindray Medical International Limited ( China ), held ...
(Date:12/2/2016)... NEW YORK , December 2, 2016 ... Market Research titled "Global Market Study on Automated Endoscope Reprocessors: ... Register a CAGR of 8.6% Between 2016 and 2024 " the ... 2015 and is expected to expand at a CAGR of ... market valuation of US$ 1,367.6 Mn by 2024. ...
Breaking Medicine Technology: